|
The Fitzpatrick Institute for Photonics (FIP)
Thursday, March 26, 2009 ~ FCIEMAS Schiciano Auditorium B~ 3:00 – 4:00pm
 |
Rebekah Drezek, Ph.D. Associate Professor Department of Bioengineering, Associate Professor Electrical & Computer Engineering Rice University Houston, Texas
|
"Optical Activatable Nanoparticles for Targeted Imaging and Therapy for Cancer"
This seminar will overview research underway at Rice University to develop optically activatable nanoparticles for molecular targeted integrated imaging and therapy of cancer. The
seminar will describe how our concept of what makes a nanoparticle
“active” has evolved over the past five years
illustrating this evolution through a series of case studies involving
several types of progressively complicated engineered nanostructures. Platform
technologies systems to be discussed will include core-shell and
multi-layered nanostructures for scatter-based imaging and photothermal
therapy of cancer, enzyme activatable quantum dot probes, and a
siRNA-based molecular beacon whose optical response is activated upon
binding sequence specific mRNA while mediating RNA interference. The
seminar will emphasize the opportunities photonics-based imaging
modalities offer in optimizing the diagnostic and therapeutic efficacy
of engineered nanomaterials in vivo.
Dr. Rebekah Drezek is an Associate Professor of Bioengineering and Associate Professor of Electrical and Computer Engineering at Rice University
where she has been on the faculty since 2002. Her lab
conducts basic science, applied, and translational research at the
intersection of medicine, photonics, and nanotechnology towards the
development of novel in vivo molecular imaging approaches with a focus
on screening, detection, and monitoring of cancer. Over the
past five years, Dr. Drezek’s research team has received
>$9M in grant support from the NIH, NSF, DOD Congressionally
Directed Medical Research Program, Beckman Foundation, Welch
Foundation, Coulter Foundation Translational Research Program, and
Center for Biological and Environmental Nanotechnology among
others. Her group has active clinical trials of new imaging
technologies underway at M.D. Anderson Cancer Center. Dr. Drezek is the principal investigator on a multi-million dollar inter-institutional Rice University and M.D. Anderson Cancer Center
project developing needle-based high resolution optical imaging
approaches and nanoengineered imaging agents for breast cancer
applications and serves as Thrust Director of a NSF Engineering Research Center
on IR Technologies for Health and the Environment. Dr. Drezek
was named one of the top 100 technology innovators in the world (MIT
TR100) in 2004, received the American Association for Medical
Instrumentation Career Achievement Award in 2005, was 1of 4 US
scientists invited to present to the NAE Frontiers in Engineering on
nanotechnology in 2006, and received the DOD Era of Hope Award for
breast cancer research in 2007 and the American Society for
Photobiology Early Career Award in 2008. Dr. Drezek serves on
the IEEE Nanotechnology Council and as annual co-chair of a SPIE
conference on optical technologies for health and the environment.
|